Symrise (FRA:SY1) has been given a €70.00 ($86.42) target price by investment analysts at Nord/LB in a research report issued on Wednesday. The brokerage currently has a “buy” rating on the stock. Nord/LB’s price objective indicates a potential upside of 12.90% from the stock’s current price.
SY1 has been the topic of several other reports. JPMorgan Chase & Co. set a €65.00 ($80.25) price target on Symrise and gave the company a “neutral” rating in a report on Monday, January 8th. Sanford C. Bernstein set a €58.00 ($71.60) price target on Symrise and gave the company a “neutral” rating in a report on Monday, January 8th. Deutsche Bank set a €78.00 ($96.30) price target on Symrise and gave the company a “buy” rating in a report on Tuesday, January 9th. Societe Generale set a €85.00 ($104.94) price target on Symrise and gave the company a “buy” rating in a report on Tuesday, December 5th. Finally, UBS Group set a €75.00 ($92.59) price target on Symrise and gave the company a “neutral” rating in a report on Thursday, December 7th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have assigned a buy rating to the company’s stock. Symrise presently has an average rating of “Hold” and a consensus target price of €68.42 ($84.47).
Symrise (FRA:SY1) traded down €4.54 ($5.60) during mid-day trading on Wednesday, reaching €62.00 ($76.54). The company had a trading volume of 1,598 shares. The company has a market cap of $7,910.00 and a PE ratio of 30.85. Symrise has a fifty-two week low of €56.96 ($70.32) and a fifty-two week high of €73.48 ($90.72).
Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.